Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
7 results loaded, newest first. End of these results.
RADNOR, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. NASDAQ:MLYS, a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and ot…
Mineralys Therapeutics, Inc. said it has issued inducement awards under Nasdaq Listing Rule 5635(c)(4).
MLYS - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
RADNOR, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. NASDAQ:MLYS, a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and ot…
Mineralys Therapeutics (MLYS) reports an inducement award granted under Nasdaq Listing Rule 5635(c)(4), with no additional terms or magnitude provided in the feed.
MLYS - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)